Clinical Considerations for Patients with Symptomatic SCD
In this podcast Shalini Shenoy, M.D., and Linda Burns, M.D., present a case study and exploration of clinical decisions for a patient with sickle cell disease (SCD). Speakers examine patient and clinical factors for determining eligibility for hematopoietic cell transplant (HCT), as well as the importance of considering clinical trials and results when treating patients with SCD.
Hematologists, oncologists, nurse practitioners, physician assistants, and other health care professionals who treat patients with SCD.
- Identify patient and clinical factors that should be considered when determining therapeutic choices for patients with sickle cell disease, including eligibility for HCT.
- Understand research that addresses trends in HCT and improvements in patient outcomes using sibling and unrelated matched donors.
- Explore HCT as a potentially curative option for SCD, and the importance of early referral for HCT consultation for patients with SCD
- Identify resources and clinical trial information to guide treatment decisions for patients with SCD
Shalini Shenoy, M.D.
Director, Pediatric Stem Cell Transplant Program, St. Louis Children’s Hospital
Interim division director, Pediatric Hematology/Oncology, Washington University School of Medicine
Linda Burns, M.D.
Vice President and Medical Director, Health Services Research
National Marrow Donor Program/Be The Match